Search Results - "VICKERMAN, P"

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database by Cornish, Rosie, Macleod, John, Strang, John, Vickerman, Peter, Hickman, Matt

“…Objective To investigate the effect of opiate substitution treatment at the beginning and end of treatment and according to duration of treatment.Design…”
Get full text

The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey by Sood, Ajit, Suryaprasad, A, Trickey, A, Kanchi, S, Midha, V, Foster, M A, Bennett, E, Kamili, S, Alvarez-Bognar, F, Shadaker, S, Surlikar, V, Garg, R, Mittal, P, Sharma, S, May, M T, Vickerman, P, Averhoff, F

“…Hepatitis C virus (HCV) infection prevalence is believed to be elevated in Punjab, India; however, state-wide prevalence data are not available. An…”
Get full text

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis by MacArthur, Georgie J, Minozzi, Silvia, Martin, Natasha, Vickerman, Peter, Deren, Sherry, Bruneau, Julie, Degenhardt, Louisa, Hickman, Matthew

“…Objective To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs.Design Systematic review and…”
Get full text

A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia by Foss, A M, Hossain, M, Vickerman, P T, Watts, C H

“…Objective: There has been much debate about the value of condoms in HIV/STI programming. This should be informed by evidence about intervention impact on…”
Get full text

Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial by Myring, G., Lim, A.G., Hollingworth, W., McLeod, H., Beer, L., Vickerman, P., Hickman, M., Radley, A., Dillon, J.F.

“…Elimination targets for hepatitis C have been set across the world. In the UK almost 90% of infections are in people who inject drugs. Evidence shows community…”
Get full text

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact by Martin, N. K., Foster, G. R., Vilar, J., Ryder, S., E. Cramp, M., Gordon, F., Dillon, J. F., Craine, N., Busse, H., Clements, A., Hutchinson, S. J., Ustianowski, A., Ramsay, M., Goldberg, D. J., Irving, W., Hope, V., De Angelis, D., Lyons, M., Vickerman, P., Hickman, M.

“…Summary Hepatitis C virus (HCV) antiviral treatment for people who inject drugs (PWID) could prevent onwards transmission and reduce chronic prevalence. We…”
Get full text

Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals? by Gliddon, H D, Ward, Z, Heinsbroek, E, Croxford, S, Edmundson, C, Hope, V D, Simmons, R, Mitchell, H, Hickman, M, Vickerman, P, Stone, J

“…In England, over 80 % of those with hepatitis C virus (HCV) infection have injected drugs. We quantified the HCV cascade of care (CoC) among people who inject…”
Get full text

High levels of transmission of HCV infection among people who inject drugs in Greece by Sypsa, V, Vickerman, P, Wiessing, L, Malliori, M, Hatzakis, A

Get full text

Is contact between men who have sex with men and non‐governmental organizations providing harm reduction associated with improved HIV outcomes? by Trickey, A, Stone, J, Semchuk, N, Saliuk, T, Sazonova, Y, Varetska, O, Lim, AG, Walker, JG, Vickerman, P

“…Objectives There is a high prevalence of HIV (5.2% in 2018) among men who have sex with men (MSM) in Ukraine. HIV testing, condom provision and facilitated…”
Get full text

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study by Vickerman, P, Hickman, M, Judd, A

“…Background Hepatitis C virus (HCV) prevalence and incidence among injecting drug users (IDUs) has increased in London and rest of UK. To inform public health…”
Get full text

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England by Harris, R. J., Martin, N. K., Rand, E., Mandal, S., Mutimer, D., Vickerman, P., Ramsay, M. E., De Angelis, D., Hickman, M., Harris, H.E.

“…Summary New direct‐acting antivirals have the potential to transform the hepatitis C (HCV) treatment landscape, with rates of sustained viral response in…”
Get full text

Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, India by Trickey, A, Sood, A, Midha, V, Thompson, W, Vellozzi, C, Shadaker, S, Surlikar, V, Kanchi, S, Vickerman, P, May, M T, Averhoff, F

“…To better understand hepatitis C virus (HCV) epidemiology in Punjab state, India, we estimated the distribution of HCV antibody positivity (anti-HCV+) using a…”
Get full text

Treatment and primary prevention in people who inject drugs (PWID) for chronic Hepatitis C (CHC): is elimination possible in a high prevalence setting? by Gountas, I, Sypsa, V, Anagnostou, O, Martin, N, Vickerman, P, Kafetzopoulos, E, Hatzakis, A

Get full text

The potential for quality assurance systems to save costs and lives: the case of early infant diagnosis of HIV by Terris‐Prestholt, F., Boeras, D., Ong, J. J., Torres‐Rueda, S., Cassim, N., Mbengue, M. A. S., Mboup, S., Mwau, M., Munemo, E., Nyegenye, W., Odhiambo, C. O., Dabula, P., Sandstrom, P., Sarr, M., Simbi, R., Stevens, W., Tucker, J. D., Vickerman, P., Ciaranello, A., Peeling, R. W.

“…Objectives Scaling up of point‐of‐care testing (POCT) for early infant diagnosis of HIV (EID) could reduce the large gap in infant testing. However, suboptimal…”
Get full text

Population network structures, graph theory, algorithms to match subgraphs may lead to better clustering of households and communities in epidemiological studies: a response by Trickey, A, Sood, A, Midha, V, Thompson, W, Vellozzi, C, Shadaker, S, Surlikar, V, Kanchi, S, Vickerman, P, May, M T, Averhoff, F

“…Regarding our work examining clustering of prevalent HCV infections in a general population setting in Punjab state, India [3], which used data from a…”
Get full text

Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue by Hickman, M., Martin, N., Vickerman, P., Hutchinson, S.

Get full text

Assessing the cost-effectiveness of finding cases of hepatitis C infection in UK migrant populations and the value of further research by Miners, A. H., Martin, N. K., Ghosh, A., Hickman, M., Vickerman, P.

“…summary Hepatitis C (HCV) infection can cause cirrhosis, liver cancer and death in the absence of treatment. Many people living in the UK but born overseas are…”
Get full text

Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan by Vickerman, P, Platt, L, Hawkes, S

“…In 2007, a survey in Rawalpindi found the prevalence of hepatitis C virus (HCV) in injecting drug users (IDUs) to be low (17%), despite widespread…”
Get more information

Cost-effectiveness of scaling up Hepatitis C virus prevention, testing and treatment interventions among people who inject drugs in the US by Barbosa, C., Fraser, H., Hoerger, T., Leib, A., Evans, J., Havens, J., Nerlander, L., Page, K., Young, A., Kral, A., Zibbell, J., Hariri, S., Vellozzi, C., Ward, J., Vickerman, P.

Get full text

P1289 CAN COMBINATION HCV PREVENTION INTERVENTIONS IN THE DAA ERA RESULT IN DRAMATIC REDUCTIONS IN HCV PREVALENCE? A MODELING ANALYSIS IN SETTINGS WITH EXISTING HARM REDUCTION by Martin, N.K, Hickman, M, Hutchinson, S.J, Goldberg, D.J, Vickerman, P

Get full text